Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Atropine sulfate 600 microgram oral tablet |
Is a |
False |
Atropine sulfate |
Inferred relationship |
Some |
|
atropinsulfat 400 µg/1 ml injektionsvæske |
Is a |
False |
Atropine sulfate |
Inferred relationship |
Some |
|
atropinsulfat 600 µg/1 ml injektionsvæske |
Is a |
False |
Atropine sulfate |
Inferred relationship |
Some |
|
atropinsulfat 800 µg/1 ml injektionsvæske |
Is a |
False |
Atropine sulfate |
Inferred relationship |
Some |
|
atropinsulfat 1 mg/1 ml injektionsvæske |
Is a |
False |
Atropine sulfate |
Inferred relationship |
Some |
|
atropinsulfat 1,25 mg/1 ml injektionsvæske |
Is a |
False |
Atropine sulfate |
Inferred relationship |
Some |
|
atropinsulfat 3 mg/10 ml i fyldt injektionssprøjte |
Is a |
False |
Atropine sulfate |
Inferred relationship |
Some |
|
atropinsulfat 3 mg/30 ml i fyldt injektionssprøjte |
Is a |
False |
Atropine sulfate |
Inferred relationship |
Some |
|
atropinsulfat 3 mg/10 ml injektionsvæske |
Is a |
False |
Atropine sulfate |
Inferred relationship |
Some |
|
atropinsulfat 1 mg/5 ml i fyldt injektionssprøjte |
Is a |
False |
Atropine sulfate |
Inferred relationship |
Some |
|
Atropine sulfate 10 mg/mL eye drops |
Is a |
False |
Atropine sulfate |
Inferred relationship |
Some |
|
Atropine sulfate 10 mg/g eye ointment |
Is a |
False |
Atropine sulfate |
Inferred relationship |
Some |
|
atropinsulfat 1 % øjendråber til engangsbrug |
Is a |
False |
Atropine sulfate |
Inferred relationship |
Some |
|
atropinsulfat 0,031 % øjendråber |
Is a |
False |
Atropine sulfate |
Inferred relationship |
Some |
|
atropinsulfat 0,062 % øjendråber |
Is a |
False |
Atropine sulfate |
Inferred relationship |
Some |
|
atropinsulfat 0,1 % øjendråber |
Is a |
False |
Atropine sulfate |
Inferred relationship |
Some |
|
Atropine sulfate 1.25 mg/mL eye drops |
Is a |
False |
Atropine sulfate |
Inferred relationship |
Some |
|
atropinsulfat 0,25 % øjendråber |
Is a |
False |
Atropine sulfate |
Inferred relationship |
Some |
|
Atropine sulfate 5 mg/mL eye drops |
Is a |
False |
Atropine sulfate |
Inferred relationship |
Some |
|
atropinsulfat 1 % øjendråber uden konserveringsmiddel |
Is a |
False |
Atropine sulfate |
Inferred relationship |
Some |
|
Atropine sulfate 20 mg/mL eye drops |
Is a |
False |
Atropine sulfate |
Inferred relationship |
Some |
|
atropinsulfat 500 µg/1 ml injektionsvæske |
Is a |
False |
Atropine sulfate |
Inferred relationship |
Some |
|
atropinsulfat 2 mg/1 ml injektionsvæske |
Is a |
False |
Atropine sulfate |
Inferred relationship |
Some |
|
atropinsulfat 500 µg/5 ml sukkerfri opløsning |
Is a |
False |
Atropine sulfate |
Inferred relationship |
Some |
|
atropinsulfat 500 µg/5 ml i fyldt injektionssprøjte |
Is a |
False |
Atropine sulfate |
Inferred relationship |
Some |
|
atropinsulfat 1 mg/10 ml i fyldt injektionssprøjte |
Is a |
False |
Atropine sulfate |
Inferred relationship |
Some |
|
Atropine sulfate 5 mg/g eye ointment |
Is a |
False |
Atropine sulfate |
Inferred relationship |
Some |
|
atropinsulfat 600 µg/1 ml i fyldt injektionssprøjte |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atropine sulfate |
Inferred relationship |
Some |
|
Atropine sulfate [antispasmodic] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atropine sulfate |
Inferred relationship |
Some |
|
Atropine sulfate 600 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atropine sulfate |
Inferred relationship |
Some |
|
Atropine sulfate [antiarrhythmic] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atropine sulfate |
Inferred relationship |
Some |
|
atropinsulfat 400 µg/1 ml injektionsvæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atropine sulfate |
Inferred relationship |
Some |
|
atropinsulfat 600 µg/1 ml injektionsvæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atropine sulfate |
Inferred relationship |
Some |
|
atropinsulfat 800 µg/1 ml injektionsvæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atropine sulfate |
Inferred relationship |
Some |
|
atropinsulfat 1 mg/1 ml injektionsvæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atropine sulfate |
Inferred relationship |
Some |
|
atropinsulfat 1,25 mg/1 ml injektionsvæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atropine sulfate |
Inferred relationship |
Some |
|
atropinsulfat 3 mg/10 ml i fyldt injektionssprøjte |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atropine sulfate |
Inferred relationship |
Some |
|
atropinsulfat 3 mg/30 ml i fyldt injektionssprøjte |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atropine sulfate |
Inferred relationship |
Some |
|
atropinsulfat 3 mg/10 ml injektionsvæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atropine sulfate |
Inferred relationship |
Some |
|
atropinsulfat 1 mg/5 ml i fyldt injektionssprøjte |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atropine sulfate |
Inferred relationship |
Some |
|
Atropine sulfate 10 mg/g eye ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atropine sulfate |
Inferred relationship |
Some |
|
atropinsulfat 1 % øjendråber til engangsbrug |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atropine sulfate |
Inferred relationship |
Some |
|
Atropine sulfate [premedication] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atropine sulfate |
Inferred relationship |
Some |
|
atropinsulfat 0,031 % øjendråber |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atropine sulfate |
Inferred relationship |
Some |
|
atropinsulfat 0,062 % øjendråber |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atropine sulfate |
Inferred relationship |
Some |
|
atropinsulfat 0,1 % øjendråber |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atropine sulfate |
Inferred relationship |
Some |
|
Atropine sulfate 1.25 mg/mL eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atropine sulfate |
Inferred relationship |
Some |
|
atropinsulfat 0,25 % øjendråber |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atropine sulfate |
Inferred relationship |
Some |
|
Atropine sulfate 5 mg/mL eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atropine sulfate |
Inferred relationship |
Some |
|
atropinsulfat 1 % øjendråber uden konserveringsmiddel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atropine sulfate |
Inferred relationship |
Some |
|
Atropine sulfate 20 mg/mL eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atropine sulfate |
Inferred relationship |
Some |
|
atropinsulfat 500 µg/1 ml injektionsvæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atropine sulfate |
Inferred relationship |
Some |
|
atropinsulfat 2 mg/1 ml injektionsvæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atropine sulfate |
Inferred relationship |
Some |
|
atropinsulfat 500 µg/5 ml sukkerfri opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atropine sulfate |
Inferred relationship |
Some |
|
atropinsulfat 500 µg/5 ml i fyldt injektionssprøjte |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atropine sulfate |
Inferred relationship |
Some |
|
atropinsulfat 1 mg/10 ml i fyldt injektionssprøjte |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atropine sulfate |
Inferred relationship |
Some |
|
Atropine sulfate 5 mg/g eye ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atropine sulfate |
Inferred relationship |
Some |
|
Atropine sulfate 1% solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atropine sulfate |
Inferred relationship |
Some |
|
Product containing precisely atropine sulfate 400 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atropine sulfate |
Inferred relationship |
Some |
|
Co-phenotrope 2500mcg/25micrograms tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atropine sulfate |
Inferred relationship |
Some |
|
Co-phenotrope |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atropine sulfate |
Inferred relationship |
Some |
|
atropinsulfat 0,025 mg + diphenoxylathydrochlorid 2,5 mg væske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atropine sulfate |
Inferred relationship |
Some |
|
Atropine sulfate 25 microgram and diphenoxylate hydrochloride 2.5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atropine sulfate |
Inferred relationship |
Some |
|
Product containing precisely atropine sulfate 19.4 microgram and hyoscyamine sulfate 103.7 microgram and scopolamine hydrobromide 6.5 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atropine sulfate |
Inferred relationship |
Some |
|
atropinsulfat 140 µg + edrophoniumchlorid 10 mg injektionsvæske til opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atropine sulfate |
Inferred relationship |
Some |
|
atropinsulfat + diphenoxylathydrochlorid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atropine sulfate |
Inferred relationship |
Some |
|
atropinsulfat + edrophoniumchlorid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atropine sulfate |
Inferred relationship |
Some |
|
atropinsulfat + hyoscyaminsulfat + scopolaminhydrobromid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atropine sulfate |
Inferred relationship |
Some |
|
Atropine sulfate 10 mg/mL eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atropine sulfate |
Inferred relationship |
Some |
|
atropin 0,025 mg + difenoxinhydrochlorid 1 mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atropine sulfate |
Inferred relationship |
Some |
|
morphinsulfat 10 mg/1 ml + atropinsulfat 600 µg/1ml injektionsvæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atropine sulfate |
Inferred relationship |
Some |
|
Atropine sulfate monohydrate (substance) |
Is a |
False |
Atropine sulfate |
Inferred relationship |
Some |
|
Atropine sulfate 600 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atropine sulfate |
Inferred relationship |
Some |
1 |
Atropine sulfate 600 microgram oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Atropine sulfate |
Inferred relationship |
Some |
1 |
Product containing precisely atropine sulfate 400 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atropine sulfate |
Inferred relationship |
Some |
1 |
Product containing precisely atropine sulfate 400 microgram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Atropine sulfate |
Inferred relationship |
Some |
1 |
Atropine sulfate 25 microgram and diphenoxylate hydrochloride 2.5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atropine sulfate |
Inferred relationship |
Some |
1 |
Atropine sulfate 25 microgram and diphenoxylate hydrochloride 2.5 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Atropine sulfate |
Inferred relationship |
Some |
1 |
Product containing precisely atropine sulfate 19.4 microgram and hyoscyamine sulfate 103.7 microgram and scopolamine hydrobromide 6.5 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atropine sulfate |
Inferred relationship |
Some |
2 |
Product containing precisely atropine sulfate 19.4 microgram and hyoscyamine sulfate 103.7 microgram and scopolamine hydrobromide 6.5 microgram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Atropine sulfate |
Inferred relationship |
Some |
2 |
Atropine sulfate 25 microgram and diphenoxylate hydrochloride 2.5 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Atropine sulfate |
Inferred relationship |
Some |
2 |
Product containing precisely atropine sulfate 19.4 microgram and hyoscyamine sulfate 103.7 microgram and scopolamine hydrobromide 6.5 microgram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Atropine sulfate |
Inferred relationship |
Some |
1 |
Atropine sulfate monohydrate (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Atropine sulfate |
Inferred relationship |
Some |
|
Atropine sulfate 500micrograms/5mL conventional release oral solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atropine sulfate |
Inferred relationship |
Some |
|
Atropine sulfate 600 microgram oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Atropine sulfate |
Inferred relationship |
Some |
1 |
Atropine sulfate 25 microgram and diphenoxylate hydrochloride 2.5 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Atropine sulfate |
Inferred relationship |
Some |
2 |
Product containing precisely atropine sulfate 400 microgram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Atropine sulfate |
Inferred relationship |
Some |
1 |
Product containing precisely atropine sulfate 19.4 microgram and hyoscyamine sulfate 103.7 microgram and scopolamine hydrobromide 6.5 microgram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Atropine sulfate |
Inferred relationship |
Some |
1 |
Atropine sulfate 1.25 mg/mL eye drops |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Atropine sulfate |
Inferred relationship |
Some |
1 |
Atropine sulfate 1.25 mg/mL eye drops |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Atropine sulfate |
Inferred relationship |
Some |
1 |
Atropine sulfate 5 mg/mL eye drops |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Atropine sulfate |
Inferred relationship |
Some |
1 |
Atropine sulfate 5 mg/mL eye drops |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Atropine sulfate |
Inferred relationship |
Some |
1 |
Atropine sulfate 20 mg/mL eye drops |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Atropine sulfate |
Inferred relationship |
Some |
1 |
Atropine sulfate 20 mg/mL eye drops |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Atropine sulfate |
Inferred relationship |
Some |
1 |
Atropine sulfate 10 mg/mL eye drops |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Atropine sulfate |
Inferred relationship |
Some |
1 |
Atropine sulfate 10 mg/mL eye drops |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Atropine sulfate |
Inferred relationship |
Some |
1 |
Atropine sulfate 10 mg/g eye ointment |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Atropine sulfate |
Inferred relationship |
Some |
1 |
Atropine sulfate 10 mg/g eye ointment |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Atropine sulfate |
Inferred relationship |
Some |
1 |
Product containing precisely atropine sulfate 1 milligram/10 milliliter conventional release solution for injection syringe |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Atropine sulfate |
Inferred relationship |
Some |
1 |
Product containing precisely atropine sulfate 1 milligram/10 milliliter conventional release solution for injection syringe |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Atropine sulfate |
Inferred relationship |
Some |
1 |
Product containing precisely atropine sulfate 1.25 milligram/1 milliliter conventional release solution for injection ampule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Atropine sulfate |
Inferred relationship |
Some |
1 |